Eruptive xanthomas secondary to severe hypertriglyceridemia

<a href="https://www.peertechzpublications.com/" target="_blank" rel="noreferrer noopener">Eruptive xanthomas secondary to severe hypertriglyceridemia Wade Hopper1, Spiro Veria2, Logan Glosser2*, Anu Garg3, Mohammed T Awad3, Justin Smith2 and Shahab Ud Din3 1 Edward via College of Osteopathic Medicine, 350 Howard St, Spartanburg, SC, 29307, USA 2 University of Toledo College of Medicine and Life Sciences, 3000 Arlington Ave, Toledo, OH, 43614, USA 3 Department of Internal Medicine, University of Toledo Medical Center, Toledo, OH, 43614, USA Received: 29 September, 2021 Accepted: 16 October, 2021 Published: 18 October, 2021 *Corresponding author: Logan D Glosser, University of Toledo College of Medicine and Life Sciences, 3000 Arlington Ave, Toledo, OH, 43614, USA, Tel: 419-705-6757; E-mail: ORCID: https://orcid.org/0000-0003-0978-7930 Keywords: Hypertriglyceridemia; Xanthoma; Hyperlipidemia; Lipid-reducing therapy; Statins Copyright: © 2021 Hopper W, et al. This is an openaccess article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. https://www.peertechzpublications.com</a>

Eruptive xanthomas secondary to severe hypertriglyceridemia Article (Faculty180)